Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 3
2(50.0%)
N/A
2(50.0%)
4Total
Phase 3(2)
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT06773806Recruiting

CHLORDECONE EXPOSURE AND PROSTATE CANCER IN THE FRENCH REGION OF MARTINIIQUE

Role: collaborator

NCT01715623Completed

Polymorphism of the IgH Locus Regulatory Region as a Prognostic Factor During Immune Pathologies.

Role: collaborator

NCT02461238Not ApplicableCompleted

Impact of Vouchers and Nutrition Education on the Consumption of Fruits and Vegetables Among Vulnerable Families (FLAM)

Role: collaborator

NCT01565577Phase 3Completed

Evaluation of Immune Response Against the Strain of Neisseria Meningitidis B: 14, P1-7, 16 Patients Vaccinated With MenBVac® (Extension MenbVac)

Role: collaborator

NCT01621945Completed

Evaluation of Immune Response Against the Strain of Neisseria Meningitidis B: 14, P1-7, 16 in Patients Having to be Vaccinated MenBVac® (Extension EFFIVAC)

Role: collaborator

NCT00646269Phase 3Completed

Efficacy Assessment of Three Non Pharmacological Therapies in Alzheimer's Disease

Role: collaborator

NCT00226720Not ApplicableCompleted

Outpatient Versus Inpatient Detoxification Program for Alcohol Dependent Patients Seeking Abstinence: The IN/OUT Study

Role: collaborator

All 7 trials loaded